3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Tobacco Use Disorder
1
Thyroid Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Mouth Neoplasms
1
Lichen Planus
1
Leukokeratosis, Hereditary Mucosal
1
Leukemia, Myeloid, Acute
1
Fanconi Anemia
1
Erythroplasia
1
COVID-19
1
Interventions
Colposcopy
10
Cryotherapy
7
Conization
6
Watchful Waiting
4
Human Papillomavirus DNA Tests
4
Acetic Acid
4
Vaginal Smears
3
Imiquimod
3
Biopsy
3
Transurethral Resection of Prostate
2
Restraint, Physical
2
High-Throughput Screening Assays
2
efineptakin alfa
1
X-Rays
1
Vision, Ocular
1
Tretinoin
1
Transdermal Patch
1
Tablets
1
Spectrum Analysis
1
Spectrometry, Fluorescence
1
Proflavine
1
Pregnancy Tests
1
Papanicolaou Test
1
Nicotine Replacement Therapy
1
Molecular Diagnostic Techniques
1
Methods
1
Mass Screening
1
Lugol's solution
1
Laser Therapy
1
Histological Techniques
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Uterine Cervical Dysplasia
×
Molecular Diagnostic Techniques
×
Clear all
NCT02328872
2026-04-17
Compass
VCS Foundation
Phase NA
Active not recruiting
76,181 enrolled